Health TrialsbyHealthPanel

Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer

ConditionCaregiving for Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorZeba Ahmad, Ph.D.

About this trial

The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Stress Management and Resiliency Training - Relaxation Response Resiliency Program; SMART-3RP (E. R. Park et al., 2021)), and iteratively incorporate feedback from parents of AYAs with cancer using a mixed-methods approach. Next, the study team will pilot the refined intervention to assess for preliminary indicators of feasibility, acceptability, and potential for efficacy in reducing parental distress.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Self-identifying parent/guardian who provides a primary informal caregiving role in their child's cancer

Recipient of caregiving is aged between 15 and 39 years and is receiving treatment for cancer at the Mass General Brigham Cancer

Participant must score equal to or greater than 2 (out of a possible 10) on the National Comprehensive Cancer Network Distress Thermometer

English-speaking

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Psychosocial Intervention for Parental Caregivers of AYA with Cancer

    Behavioral

    A new adaptation of an evidence-supported intervention, the SMART-3RP program, to address psychological symptoms and promote well-being among parental caregivers of AYA with cancer.

Treatment groups

48 Participants
are divided into 1 treatment group
Group A: Psychosocial Intervention for Parental Caregivers of AYA with Cancer-open pilot studyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Intervention Feasibility: Percent of Identified Prospective Participants Who Enroll

Percent of eligible participants who were offered participation and who enroll in the study by completing consent and baseline assessment.

Time frame
Post-treatment completion (enrollment to treatment completion is approximately 3 months)
2

Intervention Feasibility: Proportion of Participants Completing the Program

Percent of enrolled participants who complete the program, defined as completing 6 out of 8 sessions.

Time frame
Post-treatment completion (enrollment to treatment completion is approximately 3 months)
3

Intervention Acceptability

Acceptability will be assessed by the Client Satisfaction Questionnaire (CSQ-8). The intervention study will be considered acceptable if ≥80% of participants rate it as acceptable (defined as a CSQ-8 score ≥20).

Time frame
Post-treatment completion (enrollment to treatment completion is approximately 3 months)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Zeba Ahmad, Ph.D.

Lead sponsor

Massachusetts General Hospital

Sponsor institution

American Cancer Society, Inc.

Collaborator

Source ClinicalTrials.gov
Apply now